James M. Metz

Radiation Oncology
3400 Civic Center Boulevard
West Pavilion, 2nd Floor
Philadelphia, PA 19104

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 96 publications

Proton Therapy Utilization Among Adult Cancer Patients.

Proton Therapy Utilization Among Adult Cancer Patients.

Journal: International journal of particle therapy
Published: May 14, 2026

A phase 1 dual-dose escalation study of radiation and nab-paclitaxel in patients with unresectable and borderline resectable pancreatic cancer.

A phase 1 dual-dose escalation study of radiation and nab-paclitaxel in patients with unresectable and borderline resectable pancreatic cancer.

Journal: Cancer
Published: February 20, 2025

Long-term Outcomes of Definitive Chemoradiation With Proton Therapy for Treatment of Carcinoma of the Anal Canal: Combined Analysis of Two Prospective Trials.

Long-term Outcomes of Definitive Chemoradiation With Proton Therapy for Treatment of Carcinoma of the Anal Canal: Combined Analysis of Two Prospective Trials.

Journal: International journal of radiation oncology, biology, physics
Published: September 18, 2024

FLASH proton reirradiation, with or without hypofractionation, mitigates chronic toxicity in the normal murine intestine, skin, and bone.

FLASH proton reirradiation, with or without hypofractionation, mitigates chronic toxicity in the normal murine intestine, skin, and bone.

Journal: bioRxiv : the preprint server for biology
Published: July 19, 2024

FLASH proton reirradiation, with or without hypofractionation, reduces chronic toxicity in the normal murine intestine, skin, and bone.

FLASH proton reirradiation, with or without hypofractionation, reduces chronic toxicity in the normal murine intestine, skin, and bone.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: July 05, 2024

Clinical outcomes and risk stratification in unresectable biliary tract cancers undergoing radiation therapy.

Clinical outcomes and risk stratification in unresectable biliary tract cancers undergoing radiation therapy.

Journal: Radiation oncology (London, England)
Published: February 28, 2024

Factors Associated With and Characteristics of Patients Receiving Proton Therapy at the End of Life.

Factors Associated With and Characteristics of Patients Receiving Proton Therapy at the End of Life.

Journal: International journal of particle therapy
Published: November 27, 2023

FLASH radiation reprograms lipid metabolism and macrophage immunity and sensitizes medulloblastoma to CAR-T cell therapy.

FLASH radiation reprograms lipid metabolism and macrophage immunity and sensitizes medulloblastoma to CAR-T cell therapy.

Journal: Nature cancer
Published: November 22, 2023

Proton FLASH Radiotherapy Ameliorates Radiation-induced Salivary Gland Dysfunction and Oral Mucositis and Increases Survival in a Mouse Model of Head and Neck Cancer.

Proton FLASH Radiotherapy Ameliorates Radiation-induced Salivary Gland Dysfunction and Oral Mucositis and Increases Survival in a Mouse Model of Head and Neck Cancer.

Journal: Molecular cancer therapeutics
Published: September 26, 2023

FLASH Proton Radiation Therapy Mitigates Inflammatory and Fibrotic Pathways and Preserves Cardiac Function in a Preclinical Mouse Model of Radiation-Induced Heart Disease.

FLASH Proton Radiation Therapy Mitigates Inflammatory and Fibrotic Pathways and Preserves Cardiac Function in a Preclinical Mouse Model of Radiation-Induced Heart Disease.

Journal: International journal of radiation oncology, biology, physics
Published: August 21, 2023

Temporal Evolution and Diagnostic Diversification of Patients Receiving Proton Therapy in the United States: A Ten-Year Trend Analysis (2012 to 2021) From the National Association for Proton Therapy.

Temporal Evolution and Diagnostic Diversification of Patients Receiving Proton Therapy in the United States: A Ten-Year Trend Analysis (2012 to 2021) From the National Association for Proton Therapy.

Journal: International journal of radiation oncology, biology, physics
Published: June 11, 2023

SMAD4 loss predicts worse overall and distant metastasis-free survival in patients with resected pancreatic adenocarcinoma.

SMAD4 loss predicts worse overall and distant metastasis-free survival in patients with resected pancreatic adenocarcinoma.

Journal: Cancer
Published: April 19, 2023
Showing 1-12 of 96

Last Updated: 09/26/2026